Melinda A. Pruis

Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer

Melinda A. Pruis, Willemina R.R. Geurts-Giele, Thüsen J.H. von der et al. · Lung Cancer · 2019 · 60 citations · Full text

Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer

Simon P. de Leeuw, Melinda A. Pruis, Barend J. Sikkema et al. · Journal of Thoracic Oncology · 2023 · 30 citations · Full text

Oncology, Serious Weight Gain, Cancer Management +5

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer

C. Steendam, G. Veerman, Melinda A. Pruis et al. · Cancers · 2020 · 18 citations · Full text

Overcoming Acquired Resistance Mutation MET D1228N to Crizotinib With Cabozantinib in NSCLC With MET Exon 14 Skipping Mutation

Melinda A. Pruis, Marthe S. Paats, W. R. R. Geurts et al. · JCO Precision Oncology · 2021 · 15 citations · Full text

Novel Therapy, Medicine, Molecular Biology +6